argenx NV ADR (ARGX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $60.37B
Last updated: Nov 17, 2026 at 5:31 PM ET
argenx NV ADR (ARGX) Statistics
argenx NV ADR (ARGX) has a market cap of $60.37B. Its trailing P/E is 33.2x.
Total Valuation
| Market Cap | $60.37B |
|---|---|
| Latest price (Nov 17, 2026) | $950.95 |
Key Dates
| Last Earnings Date | Oct 22, 2026 |
|---|---|
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 6.0x and 176.8x.
| P/E Ratio | 33.2x |
|---|---|
| Forward P/E | 32.6x |
| P/S Ratio | 6.0x |
| P/B Ratio | 176.8x |
| P/FCF Ratio | 32.7x |
| PEG Ratio | 1.2 |
Price Statistics
The stock is up 6.64% over 52 weeks and trades 3.11% above its 50-day average.
| Beta (1Y) | 0.54 |
|---|---|
| 52-Week Change | +6.64% |
| 1-Month Change | +16.09% |
| 3-Month Change | -4.23% |
| 6-Month Change | +22.50% |
| 5-Year Change | +195.69% |
| Total Return (1Y) | +6.64% |
| Total Return (3Y CAGR) | +24.77% |
| Total Return (5Y CAGR) | +26.73% |
| Return vs SPY (1Y) | -8.03% |
| Max Drawdown (1Y) | -28.58% |
| Max Drawdown (3Y) | -31.64% |
| Sharpe Ratio (1Y) | 0.09 |
| Correlation with SPY (1Y) | 0.20 |
| 50-Day Average | $922.24 |
| 200-Day Average | $860.83 |
| 52-Week Range | $661.85 to $1,072.75 |
| RSI (14 Days) | 56.6 |
| Average Volume (20 Days) | 407.48K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Total debt is 0.00x shareholder equity.
| Debt / Equity | 0.00x |
|---|---|
| Interest Coverage | 567.24x |
Returns and Efficiency
| ROIC (5Y Average) | -5.78% |
|---|---|
| Inventory Turnover | 4.84x |
| Receivables Turnover | 9.23x |
| Cash Conversion Cycle | -31 days |
Scores
ARGX has a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 4 of 9 |
|---|---|
| Piotroski Strength | Average |
Dividends and Yields
ARGX does not pay a dividend. Its free cash flow yield is 3.06%.
| Earnings Yield | 3.01% |
|---|---|
| FCF Yield | 3.06% |
Peer Position
Against 6 similar companies, ARGX has the 3rd highest P/E.
P/E RatioPeer median 24.8x
P/S RatioPeer median 17.5x
| P/E Ratio | 33.2x vs 24.8x median |
|---|---|
| P/S Ratio | 6.0x vs 17.5x median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ARGX
What is ARGX's market cap?
argenx NV ADR has a market cap of $60.37B.
What is ARGX's P/E ratio?
argenx NV ADR has a trailing P/E ratio of 33.2x and a forward P/E of 32.6x.
How many shares of ARGX are outstanding?
argenx NV ADR has 64.89M shares outstanding.
Does ARGX pay a dividend?
No. argenx NV ADR does not pay a dividend.
ARGX pages: Overview, Charting, Statistics, Valuation, Competitors